Cardiotoxic effects of chemotherapy: A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system

HM Babiker, A McBride, M Newton, LM Boehmer… - Critical reviews in …, 2018 - Elsevier
Cardiotoxic effects of chemotherapy and targeted drugs are ubiquitous and challenging in
the field of oncology therapeutics. The broad spectrum of toxicities ranging from ischemic …

[HTML][HTML] Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome

M Olszowka, E Hagström, N Hadziosmanovic… - International Journal of …, 2024 - Elsevier
Background Sleep-related breathing disorders (SRBD) are related to cardiovascular
outcomes in patients with chronic coronary syndrome (CCS). Whether SRBD-related …

[HTML][HTML] Incremental values of AOPP, IL-6, and GDF15 for identifying arteriosclerosis in patients with obstructive sleep apnea

X Li, W Liu, Y Wang, C Zhao, Q Zhu, Z Dong… - European Journal of …, 2024 - Springer
Background The objective of this study was to determine the independent and incremental
values of advanced oxidative protein product (AOPP), interleukin 6 (IL-6), and growth …

[HTML][HTML] Both objective and paradoxical insomnia elicit a stress response involving mitokine production

M Martucci, M Conte, R Ostan, A Chiariello… - Aging (Albany …, 2020 - ncbi.nlm.nih.gov
Chronic insomnia is the most common sleep disorder in the elderly population. From 9 to
50% of patients suffer of paradoxical insomnia, with the same symptoms and ailments …

[PDF][PDF] Фибрилляция предсердий у пациентов с синдромом обструктивного апноэ во время сна и метаболическим синдромом: роль цитокинов в развитии …

ВА Ионин, ВА Павлова, АМ Ананьин… - Артериальная …, 2022 - scirate.1spbgmu.ru
Резюме Цель исследования—определить концентрации в крови биомаркеров фиброза
и воспаления для пациентов с метаболическим синдромом (МС), фибрилляцией …

Atrial fibrillation in patients with obstructive sleep apnea and metabolic syndrome: the role of cytokines in the development of left atrial myocardial fibrosis

VA Ionin, VA Pavlova, AM Ananyin… - " Arterial'naya …, 2022 - htn.almazovcentre.ru
Objective. To determine the blood concentrations of biomarkers of fibrosis and inflammation
in patients with metabolic syndrome (MS), atrial fibrillation (AF) and obstructive sleep apnea …

Учредители: УП" Профессиональные издания

ТИ Балабанович, ВИ Шишко, ВР Шулика - Рецепт, 2022 - elibrary.ru
С целью оценки диагностического потенциала фактора дифференцировки роста-15
(GDF-15) как прогностического биомаркера рецидива фибрилляции предсердий (ФП) …

The relationship between disease severity and GDF-15 in individuals diagnosed with obstructive sleep apnea syndrome

Y Boduroğlu, D Zorlu, B İlanbey… - Journal of Experimental …, 2022 - dergipark.org.tr
Obstructive sleep apnea syndrome (OSAS) is characterized with interruption of sleep with
apnea attacks and is associated with various diseases such as metabolic syndrome. GDF …

Proatherogene Genexpression in peripheren mononukleären Zellen bei obstruktiver Schlafapnoe: Effekt von Adipositas und Continuous Positive Airway Pressure …

R Boneberg - 2020 - archiv.ub.uni-marburg.de
Hintergrund, Ziele und Methode: Eine der wichtigsten schlafbezogenen Atmungsstörungen
stellt das obstruktive Schlafapnoe-Syndrom (OSAS) dar, das durch chronisch …

[PDF][PDF] Proatherogene Genexpression in peripheren mononukleären Zellen bei obstruktiver Schlafapnoe: Effekt von Adipositas und Continuous Positive Airway …

R Kinscherf - scholar.archive.org
OSAS Obstructive Sleep Apnea Syndrome PATS plasma total antioxidant status PBMC
Peripher blood mononuclear cells PBS Phosphate-buffered saline PCR Polymerase chain …